<--- Back to Details
First PageDocument Content
Transcription factors / Vascular endothelial growth factor / Hypoxia-inducible factors / Choroidal neovascularization / Retina / HIF1A / Macular degeneration / Angiogenesis / Basic helix-loop-helix / Biology / Medicine / Angiology
Transcription factors
Vascular endothelial growth factor
Hypoxia-inducible factors
Choroidal neovascularization
Retina
HIF1A
Macular degeneration
Angiogenesis
Basic helix-loop-helix
Biology
Medicine
Angiology

1720 PostScript telangiectasis in three-dimensional optical coherence tomography. Am J Ophthalmol 2006;142:340–3. 9 Gaudric A, Ducos de Lahitte G, Cohen SY, et al.

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 986,89 KB

Share Document on Facebook

Similar Documents

Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro

Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro

DocID: 1v2t4 - View Document

Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency in

Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency in

DocID: 1t4Bh - View Document

Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr

Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr

DocID: 1sS2d - View Document

Theranostics 2016, Vol. 6, Issue 11  Ivyspring International Publisher  Research Paper

Theranostics 2016, Vol. 6, Issue 11 Ivyspring International Publisher Research Paper

DocID: 1qwzN - View Document

APPLI CATI O N N O T E  Exploring gene promoters for experimentally-proven and putative transcription factor binding sites with TRANSFAC® Professional and the included Match™ tool TRANSFAC® Professional is a unique k

APPLI CATI O N N O T E Exploring gene promoters for experimentally-proven and putative transcription factor binding sites with TRANSFAC® Professional and the included Match™ tool TRANSFAC® Professional is a unique k

DocID: 1q7G9 - View Document